Stilla Technologies expands U.S. presence through strategic distribution relationship with Avantor and introduces advanced content offerings

Stilla, a pioneer in genomics and digital PCR, is excited to announce its expansion in the United States through a strategic distribution relationship with Avantor, a global leader in life sciences and advanced technology solutions.

Through this arrangement, Stilla’s comprehensive product range for digital PCR will now be readily accessible to customers across the USA, further enriching Avantor’s genomics core portfolio. This expansion facilitates the distribution of Stilla’s cutting-edge solutions through Avantor’s dedicated Life Sciences specialist team, streamlining access for researchers and clinicians alike.

Kerri McWeeny, GM North America from Stilla, expressed enthusiasm about the relationship, stating, “This collaboration implies a significant milestone for Stilla as we penetrate the USA market. With Avantor’s backing, we are well-positioned to achieve our biopharma, applied testing, and academia objectives while enhancing our applications to better serve our customers.”

Moreover, Stilla proudly announces the expansion of its content offerings to meet the evolving needs of its clientele. With a focus on Cell and Gene Therapy, biopharma quality control, infectious diseases, and applied testing, Stilla aims to provide comprehensive solutions addressing critical challenges in research and diagnostics.

Dr. Afif Abdel Nour, VP of Global Marketing at Stilla, reiterated the company’s commitment to advancing precision medicine through innovation, stating, “At Stilla, we are dedicated to propelling progress in precision medicine through relentless innovation. Our expanded sales force, global presence, and enriched product offerings underscore our unwavering support for our customers and our commitment to advancing the frontiers of molecular diagnostics.”

In related news, a recent study by Meierrieks et al. has unveiled groundbreaking findings in the titration of AAV in clarified crude cell lysate. The study compared various dPCR methods, with Stilla’s Crystal Digital® PCR technology utilizing the Ruby Chip emerging as one of the top performers.

Crystal Digital® PCR showcased exceptional results and minimal coefficient of variation (CV) with just 5 µl of total volume and 1 µl of sample. This remarkable efficiency underscores the potential of the Ruby chip for precise and reliable AAV titration, presenting significant advancements in molecular diagnostics.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Stilla Technologies. (2024, June 20). Stilla Technologies expands U.S. presence through strategic distribution relationship with Avantor and introduces advanced content offerings. News-Medical. Retrieved on July 21, 2024 from https://www.news-medical.net/news/20240620/Stilla-Technologies-expands-US-Presence-through-strategic-distribution-relationship-with-Avantor-and-introduces-advanced-content-offerings.aspx.

  • MLA

    Stilla Technologies. "Stilla Technologies expands U.S. presence through strategic distribution relationship with Avantor and introduces advanced content offerings". News-Medical. 21 July 2024. <https://www.news-medical.net/news/20240620/Stilla-Technologies-expands-US-Presence-through-strategic-distribution-relationship-with-Avantor-and-introduces-advanced-content-offerings.aspx>.

  • Chicago

    Stilla Technologies. "Stilla Technologies expands U.S. presence through strategic distribution relationship with Avantor and introduces advanced content offerings". News-Medical. https://www.news-medical.net/news/20240620/Stilla-Technologies-expands-US-Presence-through-strategic-distribution-relationship-with-Avantor-and-introduces-advanced-content-offerings.aspx. (accessed July 21, 2024).

  • Harvard

    Stilla Technologies. 2024. Stilla Technologies expands U.S. presence through strategic distribution relationship with Avantor and introduces advanced content offerings. News-Medical, viewed 21 July 2024, https://www.news-medical.net/news/20240620/Stilla-Technologies-expands-US-Presence-through-strategic-distribution-relationship-with-Avantor-and-introduces-advanced-content-offerings.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.